Elroselabs Recalls Conzerol Hydrogen Peroxide Gel Due to cGMP Deviations
Elroselabs Inc. is voluntarily recalling Conzerol Hydrogen Peroxide Gel 3% nationwide due to current Good Manufacturing Practice (cGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and is voluntary due to cGMP deviations, which aligns with the rubric for moderate severity involving voluntary precautionary recalls or minor labeling/manufacturing errors without reported illness.
Plain-English summary
Elroselabs Inc. is voluntarily recalling Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC. The product was manufactured for Elrose Labs, Inc., located in Sanford, FL. The recall was initiated on March 28, 2018, and is classified as Class II by the FDA.
The reason for the recall is current Good Manufacturing Practice (cGMP) deviations. The recall covers all product within expiry and was distributed nationwide. The recall status is currently Terminated, with a termination date of December 15, 2020.
Consumers who have this product should stop using it and contact the recalling firm for further instructions. The recall was initiated by the firm and notified via letter.
The recalled product
- Product
- Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL
- Manufacturer
- Elroselabs Inc.
- Category
- Drug — OTC Topical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All product within expiry
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Elroselabs Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Elroselabs Inc.
See all →- ModerateElroselabs Recalls Conzerol Topical Cream Due to Manufacturing Deviations
FDA (Drugs) · 2018-04-18
- ModerateElroselabs Recalls Molleave OTC Product Due to cGMP Deviations
FDA (Drugs) · 2018-04-18
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14